Loading
No description yet: the sentence for this tag has not been written. 8 records carry it: 8 people.
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Beata Halassy Virologist, Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb; Centre of Excellence for Virus Immunology and Vaccines, Zagreb Beata Halassy is a Croatian virologist who grows and characterises viruses, and is the senior author of a 2024 case report of self-experimental oncolytic virotherapy. | Triple-negative breast cancer | none | virology, croatia | ||
Dubravko Forcic Virologist, Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb; Centre of Excellence for Virus Immunology and Vaccines, Zagreb Dubravko Forcic is a Croatian virologist who works on vaccine virus strains and was joint first author of the 2024 self-experimental oncolytic virotherapy case report. | none | none | virology, croatia | ||
Howard L. Kaufman Surgical Oncologist, Massachusetts General Hospital; Chief Medical Officer, Ankyra Therapeutics · Massachusetts General Hospital Cancer Center Led OPTiM, the trial that made talimogene laherparepvec the first approved oncolytic virus therapy. | Melanoma, Merkel cell carcinoma | none | immunotherapy, melanoma | ||
John C. Bell Senior Scientist, Cancer Research Program, Ottawa Hospital Research Institute; University of Ottawa · The Ottawa Hospital Cancer Centre / Ottawa Hospital Research Institute John Bell's laboratory showed that cancer cells which have broken their interferon alarm cannot defend themselves against a virus, the mechanism the whole field is built on. | none | none | immunotherapy, canada | ||
Robert L. Martuza Neurosurgeon and researcher, Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School; Molecular Neurosurgery Laboratory and Brain Tumor Research Center · Massachusetts General Hospital Cancer Center Robert Martuza built the first genetically engineered virus designed to treat a cancer, a herpes virus crippled so that it could only replicate in dividing tumour cells. | Glioma & glioblastoma | none | neuro-oncology | ||
Stephen J. Russell Molecular medicine researcher, Mayo Clinic, Rochester; also affiliated with Vyriad, Rochester · Mayo Clinic Stephen Russell built the engineered measles viruses used against cancer and reported the case in which one intravenous dose put a patient's myeloma into complete remission. | Multiple myeloma | none | immunotherapy, myeloma | ||
Tomoki Todo Professor, Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, Institute of Medical Science, The University of Tokyo Tomoki Todo built the triple-mutated herpes virus that became the first oncolytic virus approved in Japan, and ran the trial in recurrent glioblastoma behind that approval. | Glioma & glioblastoma | none | neuro-oncology, japan | ||
Yuman Fong Chair, Department of Surgery, City of Hope · City of Hope Liver surgeon who defined who benefits from resecting colorectal liver metastases and pioneered oncolytic virus therapy. | Colorectal cancer, Hepatocellular carcinoma | none | surgery, liver |